Diabetes pharmacotherapy and effects on the musculoskeletal system.

Kalaitzoglou, Evangelia; Fowlkes, John L; Popescu, Iuliana; Thrailkill, Kathryn M

Kalaitzoglou, Evangelia; Fowlkes, John L; Popescu, Iuliana; Thrailkill, Kathryn M.

Afiliación

Kalaitzoglou E; University of Kentucky Barnstable Brown Diabetes Center Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY, USA.
Fowlkes JL; University of Kentucky Barnstable Brown Diabetes Center Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY, USA.
Popescu I; University of Kentucky Barnstable Brown Diabetes Center Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY, USA.
Thrailkill KM; University of Kentucky Barnstable Brown Diabetes Center Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY, USA.

Diabetes Metab Res Rev ; 35(2): e3100, 2019 02.

Article en En | MEDLINE | ID: mdl-30467957

Asunto(s)

Diabetes Mellitus Tipo 2/tratamiento farmacológico; Hipoglucemiantes/farmacología; Sistema Musculoesquelético/efectos de los fármacos; Humanos

Palabras clave

DPP4 inhibitors; GLP-1 agonists; SGLT2 inhibitors; alpha glucosidase inhibitors; amylin mimetics; biguanides; bone mineral density; calcium; fracture; insulin; meglitinides; muscle atrophy; muscle mass; osteoporosis; skeletal muscle; sulfonylureas; thiazolidinediones; type 1 diabetes; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Sistema Musculoesquelético Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Metab Res Rev Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google